FDA Inspection 1031034 — VIRTUS PHARMACEUTICALS OPCO II L
The FDA completed an inspection of VIRTUS PHARMACEUTICALS OPCO II L on June 9, 2017 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nashville, TN (United States)